You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temsirolimus

Showing 1 - 25 of 142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancers Trial in Houston (Temsirolimus, Metformin)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)

Not yet recruiting
  • High Grade Glioma
  • +3 more
  • Temsirolimus
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Mar 6, 2023

Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Lebanon, New Hampshire
  • +1 more
Aug 9, 2022

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Temsirolimus
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Acute Myeloblastic Leukemia Trial in Germany (sodium chloride solution 0.9%, temsirolimus)

Completed
  • Acute Myeloblastic Leukemia
  • sodium chloride solution 0.9%
  • temsirolimus
  • Berlin, Germany
  • +4 more
Nov 10, 2021

Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

Completed
Has Results
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2021

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
Has Results
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)

Active, not recruiting
  • Advanced Rare Tumours
  • Calgary, Alberta, Canada
  • +16 more
Mar 17, 2022

Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Boston (temsirolimus, cediranib)

Completed
  • Endometrial Cancer
  • +4 more
  • Boston, Massachusetts
  • +2 more
Apr 20, 2021

Relapsed Bladder Cancer Trial in France (Temsirolimus)

Completed
Has Results
  • Relapsed Bladder Cancer
  • Temsirolimus
  • Bordeaux, France
  • +8 more
Apr 9, 2021

Carcinoma, Endometrioid, mTOR Protein Trial in Barcelona, Madrid, Valencia (Temsirolimus)

Completed
  • Carcinoma, Endometrioid
  • mTOR Protein
  • Temsirolimus
  • Barcelona, Spain
  • +2 more
Nov 25, 2020

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Hepatocellular Carcinoma Trial in San Francisco, Chicago (Temsirolimus, Sorafenib:)

Completed
Has Results
  • Hepatocellular Carcinoma
  • San Francisco, California
  • +1 more
Nov 12, 2020

Hodgkin's Lymphoma Trial in Maywood (Temsirolimus)

Terminated
  • Hodgkin's Lymphoma
  • Temsirolimus
  • Maywood, Illinois
    Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Cent
Sep 14, 2020

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Peripheral Arterial Disease Trial in United States (Temsirolimus, Temsirolimus and dexamethasone sodium phosphate)

Recruiting
  • Peripheral Arterial Disease
  • Temsirolimus
  • Temsirolimus and dexamethasone sodium phosphate
  • Little Rock, Arkansas
  • +10 more
Aug 31, 2020

Glioblastoma, Adult Trial in Germany (APG101, Alectinib, Idasanutlin)

Recruiting
  • Glioblastoma, Adult
  • Berlin, Germany
  • +12 more
May 20, 2022

Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)

Completed
  • Advanced Cancer
  • Solid Tumor
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 1, 2020

Peripheral Artery Disease, Critical Limb Ischemia Trial (Temsirolimus, Saline )

Not yet recruiting
  • Peripheral Artery Disease
  • Critical Limb Ischemia
  • Temsirolimus
  • Saline placebo
  • (no location specified)
Jun 12, 2020

Chronic Limb Ischemia Trial in United States (Temsirolimus, Saline)

Unknown status
  • Chronic Limb Ischemia
  • Little Rock, Arkansas
  • +7 more
Jun 9, 2020

Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)

Unknown status
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 10, 2020